Health Trials

Tumor-Induced Osteomalacia

2

Review clinical trials related to Tumor-Induced Osteomalacia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Al18F-NOTA-LM3 PET/CT in Patients With TIO

This is a pilot study to assess the value of whole-body Al18F-NOTA-LM3 PET/CT in patients with tumor-induced osteomalacia.

Participants needed: 40
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: Peking Union Medical College HospitalUpdated: Jan 26, 2026Locations: 1
Eligibility criteria

Patients aged 18 to 80 years. [+1]

Combined with other types of tumors. [+3]

Read more
Status: Available

Expanded Access to Burosumab

Individual patient expanded access requests may be considered for patients who have no other treatment options

Trial details
Biological sex: AllType: Expanded AccessSponsor: Kyowa Kirin Co., Ltd.Updated: Mar 5, 2025
Eligibility criteria

Not listed

Read more